Shares of Alignment Healthcare, a senior-focused Medicare Advantage insurer, slumped more than 13% on Friday, closing at $7.55 after falling $1.17 on the day, amid concern about the company's California contract sub-4-star rating from the Centers for Medicare & Medicaid Services. The decline pushed shares to a new 52-week low. The ratings development sits alongside a company announcement from October 8 in which Alignment Healthcare reported that six of seven eligible Medicare Advantage contracts received four stars or higher in the CMS 2027 Star Ratings, with the California contract's failure to clear that threshold for the seventh contract drawing market attention to enrollment and bonus-payment risks the announcement itself flagged. A Seeking Alpha analysis published today identified the California Medicare Advantage contract sub-4-star rating as the central risk factor, arguing the outcome could affect bonus-payment eligibility, benefit competitiveness, enrollment, and 2027 profitability, while medical-cost inflation and broader structural pressures in the Medicare Advantage market were also cited as compounding concerns.
Alignment Healthcare LLCCalifornia Medicare Advantage contract received a sub-4-star CMS rating, threatening bonus-payment eligibility, benefits, and enrollment.
